Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
161.06
-0.88 (-0.54%)
At close: Aug 21, 2026, 4:00 PM EDT
160.71
-0.35 (-0.22%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Belite Bio Employees
Belite Bio had 41 employees as of December 31, 2025. The number of employees increased by 16 or 64.00% compared to the previous year.
Employees
41
Change (1Y)
16
Growth (1Y)
64.00%
Revenue / Employee
n/a
Profits / Employee
-$2,496,683
Market Cap
6.49B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | 16 | 64.00% |
| Dec 31, 2024 | 25 | 5 | 25.00% |
| Dec 31, 2023 | 20 | 4 | 25.00% |
| Dec 31, 2022 | 16 | 4 | 33.33% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| TG Therapeutics | 399 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Definium Therapeutics | 106 |
BLTE News
- 1 day ago - Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences - GlobeNewsWire
- 5 days ago - Belite Bio price target raised to $206 from $201 at Morgan Stanley - TheFly
- 5 days ago - Belite Bio announces FDA acceptance, priority review of tinlarebant NDA - TheFly
- 5 days ago - Belite Bio price target raised to $214 from $200 at H.C. Wainwright - TheFly
- 5 days ago - Belite Bio reports Q2 EPS (54c), consensus (78c) - TheFly
- 6 days ago - Belite Bio price target raised to $220 from $215 at Mizuho - TheFly
- 6 days ago - Belite Bio price target raised to $270 from $266 at Cantor Fitzgerald - TheFly
- 6 days ago - Belite Bio price target raised to $206 from $201 at Morgan Stanley - TheFly